Диссертация (1174270), страница 37
Текст из файла (страница 37)
– Pt.2. – P. 331—339.193.Ondo, W. Predictors of impulsivity and reward seeking behavior withdopamine agonists / W. Ondo, D. Lai // Parkinsonism Relat Disord. – 2008. –V.14. - №1. – P. 28-32.194.Parekh, P.K. Circadian clock genes: effects on dopamine, reward andaddiction / P.K. Parekh, A.R. Ozburn, C.A. McClung // Alcohol. – 2015. - V.49.- №4. – P. 341–349.195.Parhami, I. Sleep and gambling severity in a community sample ofgamblers / I.
Parhami, A. Siani, R.J. Rosenthal, S.Lin, M. Collard, T.W. Fong //Journal of Addictive Diseases. – 2012. – V.31. - №1. – P. 67–79.196.Parish J.M. Violent dreaming and antidepressant drugs: or how paroxetinemade me dream that I was fighting Saddam Hussein / J.M. Parish // J. Clin. SleepMed. – 2007. – V.3. - №5. – P. 529-531.197.Patton, J.H. Factor structure of the Barratt impulsiveness scale / J.H.Patton, M.S.
Stanford, E.S. Barratt // Journal of clinical psychology. - 1995. Vol. 51. - № 6. – P. 768-74.198.Perez-Lloret, S. Prevalence and pharmacological factors associated withimpulse-control disorder symptoms in patients with Parkinson’s disease / S.Perez-Lloret, M.V. Rey, N. Fabre, F. Ory, U. Spampinato, C. Brefel-Courbon,J.L. Montastruc, O. Rascol // Clin Neuropharmacol. – 2012. – V.35. - №6. – P.261-265.199.Peterson, E. Pathological gambling: Relation of skin conductance responseto dopaminergic neurotransmission and sensation-seeking / E.
Peterson, A.Moller, D.J. Doudet, C.J. Bailey, K.V. Hansen, A. Rodell, J. Linnet, A. Gjedde //Eur Neuropsychopharmacol. – 2010. – V.20. - №11. – P. 766-775.200.Peto, V. PDQ-39: a review of the development, validation and applicationof a Parkinson’s disease quality of life questionnaire and its associated measures211/ V. Peto, C. Jenkinson, R. Fitzpatrick // J Neurol. – 1998. – V.
245. – Suppl. 1. –P. 10—14.201.Peto, V. The development and validation of a short measure of functioningand well being for individuals with Parkinson’s disease / V. Peto, C. Jenkinson,R. Fitzpatrick, R. Greenhall // Quality Life Res. – 1995. – V.4. – №3. - P. 241–428.202.Pezzella, F.R. Prevalence and clinical features of hedonistic homeostaticdysregulation in Parkinson’s disease / F.R. Pezzella, C. Colosimo, N. Vanacore,S. Di Rezze, M. Chianese, G.
Fabbrini, G. Meco // Mov Disord. – 2005. – V.20.- №1. – P. 77–81.203.Phu, A. Effect of impulse control disorders on disability and quality of lifein Parkinson’s disease patients / A.L. Phu, Z. Xu, V. Brakoulias, N. Mahant, V.S.Fung, G.D. Moore, A. Martin, V. Starcevic, M. Krause // J Clin Neurosci.
–2014. – V.21. - №1. – P. 63-66.204.Poletti, M. A single-center, cross-sectional prevalence study of impulsecontrol disorders in Parkinson’s disease: association with dopaminergic drugs /M. Poletti, C. Logi, C. Lucetti, P. Del Dotto, F. Baldacci, A. Vergallo, M. Ulivi,S. Del Sarto, G. Rossi, R. Ceravolo, U. Bonuccelli // J Clin Psychopharmacol. –2013. – V.33. - №5.
– P. 691–4.205.Poletti, M. Impulse control disorders in Parkinson’s disease: the role ofpersonality and cognitive status / M. Poletti, U. Bonuccelli // J Neurol. – 2012. –V.259. -№11. – P. 2269-77.206.Pontieri, F.E. Sociodemographic, neuropsychiatric and cognitivecharacteristics of pathological gambling and impulse control disorders NOs inparkinson's disease / F.E. Pontieri, F. Assogna, C. Pellicano, C.
Cacciari, S.Pannunzi, A. Morrone, E. Danese, C. Caltagirone, G. Spalletta // EurNeuropsychopharmacol. – 2015. – V.25. - №1. – P. 69–76.207.Pontone, G. Clinical features associated with impulse control disorders inParkinson’s disease / G. Pontone, J.R. Williams, S.S.
Bassett, L. Marsh //Neurology. – 2006. – V.67. - №7. – P. 1258-61.212208.Peterson, E. Pathological gambling: Relation of skin conductance responseto dopaminergic neurotransmission and sensation-seeking / E. Peterson, A.Moller, D.J. Doudet, C.J. Bailey, K.V. Hansen, A. Rodell, J. Linnet, A. Gjedde //Eur Neuropsychopharmacol.
– 2010. – V.20. - №11. – P. 766-775.209.Potenza, M.N. Should addictive disorders include non–substance-relatedconditions? / M.N. Potenza // Addiction. – 2006. – V. 101. - Suppl. 1. – P. 142–151.210.Pourcher, E. Compulsive habits in restless legs syndrome patients underdopaminergic treatment / E. Pourcher, S. Rémillard, H. Cohen // J Neurol Sci.
–2010. – V.290. -№1-2. – P. 52–56.211.Quinn, N. Young onset Parkinson’s disease / N. Quinn, P.Critchley, C.D.Marsden // Mov.Disord. – 1987. – V.2. - №2. – P. 73– 91.212.Rabinak, C.A. Dopamine agonist withdrawal syndrome in Parkinson’sdisease / C.A. Rabinak, M.J. Nirenberg // Arch Neurol. - .2010.- V.67. – P. 58-63.213.Raina, G.
Zoophilia and impulse control disorder in a patient withParkinson’s disease / G. Raina, M.G. Cersosimo, F. Micheli // Journal ofNeurology. – 2012. – V.259. - №5. – P. 969–970.214.Rao, H. Decreased ventral striatal activity with impulse control disorders inParkinson’s disease / H. Rao, E. Mamikonyan, J.A. Detre, A.D. Siderowf, M.B.Stern, M.N. Potenza, D. Weintraub // Mov Disord. – 2010.
– V.25. - №11. – P.1660-1669.215.Ratti, P.L. REM and NREM sleep enactment behaviors in Parkinson’sdisease, Parkinson’s disease dementia, and dementia with Lewy bodies / P.L.Ratti, M. Terzaghi, B. Minafra, A. Repetto, C. Pasotti, R. Zangaglia, C.Pacchetti, R. Manni // Sleep Med. – 2012. – V.13. - №7. – P.
926—932.216.Results from the 2009 National Survey on Drug Use and Health: Volume I.Summary of National Findings - [Электронный ресурс]. – Режим доступа:http://www.gmhc.org/files/editor/file/a_pa_nat_drug_use_survey.pdf (датаобращения: 12.12.2018).213217.Reuter, J. Pathological gambling is linked to reduced activation of themesolimbic reward system / J. Reuter, T. Raedler, M.
Rose, I. Hand, J. Glascher,C. Buchel // NatNeurosci. – 2005. – V.8. - №2. – P. 147-148.218.Ricciardi, L. Phenotypic variability of PINK1 expression: 12 years' clinicalfollow-up of two Italian families / L. Ricciardi, S. Petrucci, A. Guidubaldi, T.Ialongo, L. Serra, A. Ferraris, B. Spanò, M. Bozzali, E.M. Valente, A.R.Bentivoglio // Mov Disord. – 2014. – V. 29. - №12. – P.1561–1566.219.Riley, D.E. Reversible transvestic fetishism in a man with Parkinson’sdisease treated with selegiline / D.E. Riley // Clin Neuropharmacol. – 2002. –V.25. - №4.
– P. 234–237.220.Riley, M. Demographic and Clinical Predictors of Trait Impulsivity inParkinson's Disease Patients / M. Riley, M. Bakeberg, M. Byrnes, A. Jefferson,S. Ghosh, R. Stell, F.L. Mastaglia, D. Hince, R.S. Anderton // Parkinsons Dis. –2018. – 9472120.221.Rodriguez-Violante, M. Impulse control and related disorders in MexicanParkinson’s disease patients / M.
Rodríguez-Violante, P. González-Latapi, A.Cervantes-Arriaga, A. Camacho-Ordoñez, D. Weintraub // Parkinsonism RelatDisord. – 2014. – V.20. - №8. – P. 907-10.222.Rohde, K. Impulsive-compulsive behaviours in a German Parkinson’sdisease outpatient sample / K. Rohde, O.
Riedel, U. Lueken, S. Rietzel, M.Fauser, C. Ossig, H. Reichmann, A. Storch // Fortschr Neurol Psychiatr. – 2013.– V.81. – P. 503-10.223.Romenets, S.R. Rapid eye movement sleep behavior disorder and subtypesof Parkinson’s disease / S.R. Romenets, J.F. Gagnon, V. Latreille, M. Panniset, S.Chouinard, J. Montplaisir, R.B. Postuma // Mov Disord. – 2012. – V.
27. - №8. –P. 996–1003.224.Rowe, J.B. Parkinson’s disease and dopaminergic therapy – differentialeffects on movement, reward and cognition / J.B. Rowe, L. Hughes, B.C. Ghosh,D. Eckstein, C.H. Williams-Gray, S. Fallon, R.A. Barker, A.M. Owen // Brain. –2008. – V.131. – Pt.8.
– P. 2094-2105.214225.Rylander G. Psychoses and the punding and choreiform syndromes inaddiction to central stimulant drugs / G. Rylander // Psychiatr Neurol Neurochir.– 1972. – V.75. - №3. – P. 203–212.226.Rylander, G. Preludin addiction from the clinical and medical-criminological point of view / G. Rylander // Lakartidningen. – 1966. – V.
63. №52. – P. 4973–4980.227.Sarathchandran, P. Impulse control disorders and related behaviors inIndian patients with Parkinson's disease / P. Sarathchandran, S. Soman, G.Sarma, S. Krishnan, A. Kishore // Mov Disord. – 2013. – V.28. - №13. – P.1901–2.228.Schenck, C.H. Chronic behavioral disorders of human REM sleep: a newcategory of parasomnia / C.H. Schenck, S.R. Bundlie, M.G. Ettinger, M.W.Mahowald // Sleep. – 1986.
– V.9. – P. 293—308.229.Schenck, C.H. REM sleep behavior disorder: clinical, developmental, andneuroscience perspectives 16 years after its formal identification in SLEEP /C.H. Schenck, M.W. Mahowald // Sleep. – 2002. – V.25. - №2. – P. 120–38.230.Scher, J. Patterns and profiles of addiction and drug abuse / J. Scher // ArchGen Psychiatry. – 1966.
– V.15. – P. 539–551.231.Schiorring, E. Changes in individual and social behaviour induced byamphetamine and related compounds in monkeys and man. In: E.H. Ellinwood,M.M. Kilbey, editors. Cocaine and other stimulants. New York: Plenum Press,1977.
- p 481–522.232.Schlüter, T. MAOA-VNTR polymorphism modulates context-dependentdopamine release and aggressive behavior in males / T. Schlüter, O. Winz, K.Henkel, T. Eggermann, S. Mohammadkhani-Shali, C. Dietrich, A. Heinzel, M.Decker, P. Cumming, K. Zerres, M. Piel, F.M. Mottaghy, I. Vernaleken //Neuroimage. – 2016. – V. 15. - №125. – P.
378-385.233.Scullin, M.K. Sleep and impulsivity in Parkinson’s disease / M.K. Scullin,A.B. Sollinger, J. Land, C. Wood-Siverio, L. Zanders, R. Lee, A. Freeman, F.C.215Goldstein, D.L. Bliwise, S.A. Factor // Parkinsonism Relat Disord. – 2013. –V.19. - №11.
– P. 991–4.234.Seedat, S. Pathological gambling behavior: emergence secondary totreatment of Parkinson’s disease with dopaminergic agents / S. Seedat, S. Kesler,D.J. Niehaus, D.J. Stein DJ // Depress. Anxiety. – 2000. – V.11. - №4. – P. 1856.235.Sensi, M. Explosive-aggressive behavior related to bilateral subthalamicstimulation / M. Sensi, R. Eleopraa, M.A. Cavallo, E.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
